2005 CASH FLOW - 006
96911 - Harvard Pilgrim Health Care Inc
| |
Line |
Description |
Current Year |
Prior Year |
| 01 |
Premiums collected net of reinsurance |
|
2,012,388,213 |
2,093,147,744 |
| 02 |
Net investment income |
|
22,639,516 |
16,785,587 |
| 03 |
Miscellaneous income |
|
6,226,678 |
-5,291,925 |
| 04 |
Total |
|
2,041,254,407 |
2,104,641,406 |
| 05 |
Benefit and loss related payments |
|
1,732,118,096 |
1,812,917,386 |
| 06 |
Net transfers to Separate, Segregated Accounts and Protected Cell Accounts |
|
0 |
0 |
| 07 |
Commissions, expenses paid and aggregate write-ins for deductions |
|
228,879,854 |
233,969,079 |
| 08 |
Dividends paid to policyholders |
|
0 |
0 |
| 09 |
Federal and foreign income taxes paid (recovered) $0 net tax on capital gains (losses) |
|
0 |
0 |
| 10 |
Total |
|
1,960,997,950 |
2,046,886,465 |
| 11 |
Net cash from operations |
|
80,256,457 |
57,754,941 |
| 12.1 |
Bonds (proceeds from investments sold, matured or repaid) |
|
542,180,519 |
617,496,174 |
| 12.2 |
Stocks (proceeds from investments sold, matured or repaid) |
|
0 |
0 |
| 12.3 |
Mortgage loans (proceeds from investments sold, matured or repaid) |
|
0 |
0 |
| 12.4 |
Real estate (proceeds from investments sold, matured or repaid) |
|
0 |
0 |
| 12.5 |
Other invested assets (proceeds from investments sold, matured or repaid) |
|
1,032,335 |
803,857 |
| 12.6 |
Net gains (losses) on cash, cash equivalents and short- term investments |
|
-58,807 |
-101,607 |
| 12.7 |
Miscellaneous proceeds (proceeds from investments sold, matured or repaid) |
|
3,978,819 |
21,204,980 |
| 12.8 |
Total investment proceeds (proceeds from investments sold, matured or repaid) |
|
547,132,866 |
639,403,404 |
| 13.1 |
Bonds (cost of investments acquired - long-term only) |
|
589,957,067 |
731,803,639 |
| 13.2 |
Stocks (cost of investments acquired - long-term only) |
|
5,807,088 |
0 |
| 13.3 |
Mortgage loans (cost of investments acquired - long-term only) |
|
0 |
0 |
| 13.4 |
Real estate (cost of investments acquired - long-term only) |
|
1,215,439 |
209,158 |
| 13.5 |
Other invested assets (cost of investments acquired - long-term only) |
|
0 |
0 |
| 13.6 |
Miscellaneous applications (cost of investments aquired - long-term only) |
|
14,980,511 |
0 |
| 13.7 |
Total investments acquired (cost of investments aquired - long-term only) |
|
611,960,105 |
732,012,797 |
| 14 |
Net increase (or decrease) in contract loans and premium notes |
|
0 |
0 |
| 15 |
Net cash from investments |
|
-64,827,239 |
-92,609,393 |
| 16.1 |
Surplus notes, capital notes (cash provided/applied) |
|
-14,836,627 |
-6,641,235 |
| 16.2 |
Capital and paid in surplus, less treasury stock (cash provided/applied) |
|
0 |
0 |
| 16.3 |
Borrowed funds (cash provided/applied) |
|
0 |
0 |
| 16.4 |
Net deposits on deposit-type contracts and other insurance liabilities (cash provided/applied) |
|
0 |
0 |
| 16.5 |
Dividends to stockholders (cash provided/applied) |
|
0 |
0 |
| 16.6 |
Other cash provided (applied) |
|
-13,638,483 |
-32,293 |
| 17 |
Net cash from financing and miscellaneous sources |
|
-28,475,110 |
-6,673,528 |
| 18 |
Net change in cash, cash equivalents and short-term investments |
|
-13,045,892 |
-41,527,980 |
| 19.1 |
Beginning of year (cash, cash equivalents and short-term investments) |
|
60,441,478 |
101,969,458 |
| 19.2 |
End of year (cash, cash equivalents and short-term investments) |
|
47,395,586 |
60,441,478 |
| 20.0001 |
Supplemental disclosures of cash flow information for non-cash transactions |
NO NON-CASH TRANSACTIONS TO REPORT |
0 |
0 |
Last Updated:
February 12, 2009
|
